Boots has rolled out dedicated GLP-1 zones across more than 220 stores, curating products aimed at the common side effects of rapid weight loss. The edit spans gut and digestive support, skin elasticity, hair loss, sleep, energy and nutrition, grouping the categories a GLP-1 user might otherwise hunt for separately.
Join European founders, operators, and investors who read The Checkout every week.
It is a notable piece of retail category-building around the weight-loss drug boom. Rather than only selling the treatment, Boots is helping consumers with the wider journey, and its own-brand Wellthy range features prominently, alongside listed products including an OGX scalp serum (£8.50), and Absolute Collagen's GLP-1-formulated Sculpt Pro (£45).
The zones sit alongside Boots' clinical offer: a private in-store weight-loss treatment service providing GLP-1 access for eligible customers, its digital Boots Online Doctor service, and Independent Prescribing Pharmacists on hand in store.
"By carefully selecting products that provide all-round support and making them easy to find, we can best help customers and cater for what they need," said Jamie Kerruish, chief healthcare officer at Boots.
AUTHOR
SUPPORTED BY PAPER RUN
Paper Run helps brands win back customers that email can't reach through automated direct mail that integrates with Shopify & Klaviyo.
SUPPORTED BY WAYFLYER
Wayflyer provides purpose-built financing to consumer brands worldwide, deploying over $6 billion to 7,000+ businesses since launching in 2020. Their data-led underwriting model and deep industry expertise enables them to deploy capital in hours, not weeks - a speed traditional lenders simply can't match.
JOIN OUR FOUNDER NETWORK:
VENICE FOUNDERS NETWORK
Where 200+ European consumer founders solve problems together.
An independent space for Europe's Consumer Founders & CEO's.
